Items where Author is "Sure, U."

Article

Guberina, N. and Poettgen, C. and Kebir, S. and Lazaridis, L. and Scharmberg, C. and Luebcke, W. and Niessen, M. and Guberina, M. and Scheffler, B. and Jendrossek, V and Jabbarli, R. and Pierscianek, D. and Sure, U. and Schmidt, T. and Oster, C. and Hau, P. and Grosu, A. L. and Stuschke, M. and Glas, M. and Nour, Y. and Luedemann, L. (2020) Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial. RADIATION ONCOLOGY, 15 (1): 83. ISSN 1748-717X

Conference or Workshop Item

Lazaridis, L. and Schmidt, T. and Agkatsev, S. and Blau, T. and Spille, D. and Heider, S. and Schulz, T. and Bumes, E. and Oster, C. and Feldheim, J. and Stummer, W. and Kessler, A. and Seidel, C. and Hau, Peter and Sure, U. and Keyvani, K. and Herrlinger, U. and Kleinschnitz, C. and Stuschke, M. and Herrmann, K. and Deuschl, C. and Hattingen, E. and Scheffler, B. and Kebir, S. and Glas, M. (2022) P11.15.B First multicentric real-life experience with the combination of lomustine and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma. In: 17th Meeting of the European Association of Neuro-Oncology, September 15th - 18th, 2022, Vienna, Austria.

Kebir, S. and Pierscianek, D. and Proescholdt, M. and Hau, P. and Grosu, A. and Krex, D. and Sure, U. and Scheffler, B. and Stuschke, M. and Glas, M. (2021) PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA. In: 16th Meeting of the European Association of Neuro-Oncology, September 25 - 26, 2021, Virtual.

Guberina, N. and Poettgen, C. and Kebir, S. and Lazaridis, L. and Scharmberg, C. and Luedemann, L. and Niessen, M. and Guberina, M. and Scheffler, B. and Jendrossek, V and Jabbarli, R. and Pierscianek, D. and Sure, U. and Schmidt, T. and Oster, C. and Hau, P. and Grosu, A. and Stuschke, M. and Glas, M. and Nour, Y. and Luebcke, W. (2020) Evaluation of the dosimetric Effects of geometric Variation of Tumor Treating Field (TTF) Electrode Positioning in the PriCoTTF Phase I/II Study. In: 26th Annual Conference of the German-Society-for-Radiation-Oncology (DEGRO), 2020, Wiesbaden, GERMANY.

Kebir, S. and Lazaridis, L. and Schmidt, T. and Oster, C. and Pierscianek, D. and Guberina, N. and Kleinschnitz, C. and Proescholdt, M. and Hau, P. and Grosu, A.-L. and Sure, U. and Scheffler, B. and Stuschke, M. and Glas, M. (2020) PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma. In: 26th Annual Conference of the German-Society-for-Radiation-Oncology (DEGRO), 2020, Wiesbaden, GERMANY.

Other

Glas, M. and Scheffler, B. and Lazaridis, L. and Herrlinger, U. and Pierscianek, D. and Sure, U. and Proescholdt, M. and Hau, P. and Hense, J. and Kleinschnitz, C. and Grosu, A. and Stuschke, M. and Kebir, S. (2018) PRICOTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

Glas, M. and Scheffler, B. and Lazaridis, L. and Herrlinger, U. and Pierscianek, D. and El Hindy, N. and Sure, U. and Proescholdt, M. and Hau, P. and Hense, J. and Kleinschnitz, C. and Combs, S. E. and Grosu, A. -L. and Stuschke, M. and Kebir, S. (2018) PriCoTTF: A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastoma. SPRINGER HEIDELBERG, HEIDELBERG.